文献
J-GLOBAL ID:202202213881059640
整理番号:22A0902561
初回転移性トリプルネガティブ乳癌における化学療法対化学療法単独に対する免疫チェックポイント阻害剤の追加:系統的レビューとメタ分析【JST・京大機械翻訳】
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
著者 (15件):
Villacampa Guillermo
(SOLTI Breast Cancer Research Group, Barcelona, Spain)
,
Villacampa Guillermo
(Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)
,
Tolosa Pablo
(SOLTI Breast Cancer Research Group, Barcelona, Spain)
,
Tolosa Pablo
(Hospital Universitario 12 de Octubre, Madrid, Spain)
,
Salvador Fernando
(SOLTI Breast Cancer Research Group, Barcelona, Spain)
,
Sanchez-Bayona Rodrigo
(Hospital Universitario 12 de Octubre, Madrid, Spain)
,
Villanueva Lorea
(SOLTI Breast Cancer Research Group, Barcelona, Spain)
,
Dienstmann Rodrigo
(Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain)
,
Ciruelos Eva
(SOLTI Breast Cancer Research Group, Barcelona, Spain)
,
Ciruelos Eva
(Hospital Universitario 12 de Octubre, Madrid, Spain)
,
Ciruelos Eva
(Centro Integral Oncologico Clara Campal HM (CIOCC), Madrid, Spain)
,
Pascual Tomas
(SOLTI Breast Cancer Research Group, Barcelona, Spain)
,
Pascual Tomas
(Department of Medical Oncology, Hospital Clinic of Barcelona, Spain)
,
Pascual Tomas
(Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain)
,
The Institute of Cancer Research, London, United Kingdom
資料名:
Cancer Treatment Reviews
(Cancer Treatment Reviews)
巻:
104
ページ:
Null
発行年:
2022年
JST資料番号:
W1768A
ISSN:
0305-7372
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)